Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: The GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
Anette Gabriele Ziegler, Peter Achenbach, Reinhard Berner, Kristina Casteels, Thomas Danne, Melanie Gündert, Joerg Hasford, Verena Sophia Hoffmann, Olga Kordonouri, Karin Lange, Helena Elding Larsson, Markus Lundgren, Matthew D. Snape, Agnieszka Szypowska, John A. Todd, Ezio Bonifacio
Research output: Contribution to journal › Article › peer-review
72Scopus
citations
Fingerprint
Dive into the research topics of 'Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: The GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol'. Together they form a unique fingerprint.